Connect with us

Technology

EQT AB (publ) Q1 Announcement 2025

Published

on

STOCKHOLM, April 16, 2025 /PRNewswire/ — A global platform equipped to navigate uncertain markets
“The world is once again facing significant economic and geopolitical uncertainty. After a strong first quarter in terms of fundraising, exits, and investments, we are now navigating a new market environment. Our portfolio is thematically invested across sectors such as healthcare, software, and essential infrastructure with limited direct exposure to tariffs. As we look ahead, exit activity will slow down, but periods of disruption often bring compelling investment opportunities. With more than EUR 50 billion of dry powder1, we are well-positioned to navigate uncertainty to the benefit of our clients and shareholders. Over our 30 year history, we have managed volatility and multiple cycles, emerging stronger each time.”

Christian Sinding,
CEO and Managing Partner

Highlights for the period Jan-Mar 2025 (Jan-Mar 2024)

Strategic

EQT introduced EQT Nexus Infrastructure, its latest evergreen strategy available for individual and institutional investors in EMEA, APAC and Canada. The product offers exposure to EQT’s infrastructure strategies and direct investments in infrastructure companies in EQT’s portfolio. EQT now has three products available for private wealthEQT expects to launch a U.S. evergreen product during the summer with two global distributors; one private bank and one wirehouse. The product will invest across the Private Capital platform. Furthermore, preparations continue for a U.S. evergreen product focused on Infrastructure

Fundraising

FAUM increased to €142bn (€132bn) and Total AUM amounted to €273bn (€242bn). Gross inflows amounted to €12bn, primarily driven by closed out commitments from BPEA IX and EQT Infrastructure VIEQT Infrastructure VI closed at €21.5bn in total commitments, including €21.3bn in fee-generating commitments, exceeding its €20bn target and hitting its €21bn hard-cap. The final size represents a 35% increase on the fund’s predecessor, owing to strong support from both existing and new investorsBPEA Private Equity Fund IX was activated on 1 March 2025. As of 16 April 2025, it has received commitments of more than $10bn. The fund will hold its first close during April and is expected to reach its target fund size of $12.5bn during the summer. Fundraising is expected to materially conclude during the second half of the year. As previously communicated, the hard-cap for investor commitments for BPEA IX is $14.5bn

Investment performance

All Key funds continued to perform On or Above plan. Key fund valuations increased by on average 1% during the quarter. The performance of more recent vintages in Private Capital was particularly strong, as recent investments continued to perform ahead of plan. Strong underlying performance across the portfolio was partly offset by lower share prices for listed holdings in EQT VIII, EQT Infrastructure IV, and BPEA VIII; specific pockets of underperformance; and negative FX effectsEQT’s portfolio companies have limited direct exposure to the recently announced tariffs. The EQT funds in Private Capital are primarily invested in sectors such as Healthcare, Software, and Services, with no or limited exposure to manufacturing or trading of physical goods. However, a deterioration in global GDP growth, inflation, or constrained financial markets, as well as factors such as changes in supply chains and trade patterns, would likely have secondary effects on the portfolio companiesThe recent deterioration in market conditions and lower public market valuation references may negatively impact the EQT fund valuations in Q2

Investment activity

Total investments by the EQT funds amounted to €4bn. EQT was particularly active in our key sub-sectors such as digital infrastructure, energy transition, education, healthcare, software, and logistics real estate. In addition, EQT provided co-investment opportunities of almost €4bn for its clients

Exit activity

EQT announced total gross fund exits of €4bn, more than doubling the more muted exit volumes in Q1 2024In March, EQT Private Capital Asia closed its largest exit to-date as EQT, as part of a global consortium of premier institutional investors, completed the acquisition of Nord Anglia Education from BPEA VI and co-investors. Through the investment from BPEA VIII, EQT will continue to serve as a long-term partner to Nord Anglia, creating further value creation opportunities for its clientsPublic market exits represented approximately a third of total exit volumes during Q1, with sell-downs in EQT VIII’s listed holdings Galderma, Azelis, and Waystar; and EQT Infrastructure III and VI’s holdings in KodiakHaving executed on its exit agenda throughout the first quarter, EQT expects a material slow down in exit activity given the recent deterioration in market conditions and elevated uncertainty across global markets

People

The Board of Directors appointed Per Franzén as CEO and Managing Partner, effective as of the Annual Shareholders’ Meeting on 27 May 2025. Christian Sinding will become an Institutional Partner and in this role, he will Chair the EQT Council. He will also continue to Chair the Global Investment Forum and remain a member of several Investment CommitteesBert Janssens and Eric Liu were appointed Co-Heads of EQT Private Capital Europe & North AmericaThe Nomination Committee has proposed Jacob Wallenberg Jr as a new Board member of EQT. The proposal is subject to approval at EQT’s Annual Shareholders’ Meeting on 27 May 2025The number of full-time equivalent employees (FTE) amounted to 1,893 (1,802). As of 2025, EQT will no longer report FTE+ (FTE including on-site consultants). In line with previous reporting, costs of on-site consultants are reported as Other operating expenses

Other

The Board of Directors resolved to repurchase a maximum of approximately 4.9 million own ordinary shares, corresponding to 0.4% of EQT’s share capital. As previously announced, EQT intends to execute share buyback programs twice a year to offset – over time – the dilution impact from shares delivered to EQT’s employees under its Share and Option incentive programs. EQT repurchased approximately 1.5 million shares during the first quarterAt the end of the period, the number of portfolio companies with validated science-based targets amounted to 54, representing more than 65% of invested capital. In addition, 15 companies are in the process of setting targetsEQT is considering further diversifying its funding base. EQT currently has three bonds outstanding with a total nominal value of €2bn, maturing in 2028, 2031 and 2032, respectively, as well as an undrawn RCF of €1.5bn. EQT is rated A- by both Fitch and S&POn 22 May 2025, EQT will host a capital markets event in London focused on EQT’s active ownership model and approach to value creation, featuring insights from portfolio company CEOs, Chairpersons, Industrial Advisors, and EQT’s leadership team

Events after the reporting period

EQT Infrastructure VI announced the acquisition of Eagle Railcar Services, and EQT X announced the acquisition of WTS. Both investments were agreed and therefore accounted for in Q1 2025EQT VIII and EQT IX announced the partial sale of IFSEQT VIII announced the sale of Karo HealthcareInvestment levels in EQT Key funds as of 16 April 2025 were 50-55% in EQT X, 45-50% in EQT Infrastructure VI and 0-5% in BPEA IX

1) Undrawn commitments in funds in investment mode (based on closed transactions)

Presentation of EQT AB’s Q1 Announcement 2025

Financial analysts and media are invited to participate in a conference call, including a presentation at 08:30 CEST.

The presentation and a link to follow the webcast and conference call live can be found here and a recording will be available afterwards.

To participate by phone, please register here. You will then receive your personal dial-in details, to be able to ask questions during the Q&A.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact:

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, shareholderrelations@eqtpartners.com 

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, press@eqtpartners.com, +46 8 506 55 334

This is information that EQT AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 07:00 CEST on 16 April 2025.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/eqt-ab–publ–q1-announcement-2025,c4136681

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/eqt-ab-publ-q1-announcement-2025-302430000.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING

Published

on

By

NEW YORK, May 5, 2026 /PRNewswire/ — Vernal Capital Acquisition Corp. (NYSE: VECA) (“Vernal”) announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at $10.00 per unit. The units are expected to trade on the New York Stock Exchange (“NYSE”) under “VECAU” beginning May 6, 2026. Each unit consists of one ordinary share and one right to receive one-fourth of one ordinary share upon consummation of an initial business combination. Upon separate trading, the ordinary shares and rights are expected to be listed on NYSE under “VECA” and “VECAR,” respectively.

D. Boral Capital LLC is acting as sole book-running manager of the offering. The underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover any over-allotments. The offering is expected to close on May 7, 2026, subject to customary closing conditions.

A registration statement for these securities was declared effective by the SEC on May 5, 2026. The offering is made only by means of a prospectus. Copies of the prospectus may be obtained, from D. Boral Capital LLC, 590 Madison Ave., 39th Floor, New York, New York 10022, by telephone at (212) 970-5150 or by email at dbccapitalmarkets@dboralcapital.com.

This press release shall not constitute an offer to sell or to buy, nor shall there be any sale where such offer, solicitation or sale would be unlawful prior to registration or qualification under the applicable securities laws.

About Vernal

Vernal is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Vernal’s target search will not be limited to a particular industry or geographic region.

Forward-Looking Statements

This press release contains “forward-looking statements,” including statements regarding Vernal’s IPO. These statements are subject to risks and uncertainties that could cause actual results to differ materially. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, beyond Vernal’s control, including those in the Risk Factors section of Vernal’s registration statement filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Vernal disclaims any obligation to release publicly updates or revisions to any forward-looking statements to reflect any change in Vernal’s expectations, except as required by law.

Contact

Binghan Yi, CFO
binghan@vernal.com
www.vernalspac.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vernal-capital-acquisition-corp-announces-pricing-of-100-million-initial-public-offering-302763378.html

SOURCE Vernal Capital Acquisition Corp.

Continue Reading

Technology

RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America

Published

on

By

Nomination places the Charlottesville-based company among growth-stage medtech leaders recognized for commercial momentum in AI-powered clinical decision support; public voting is open through May 8

CHARLOTTESVILLE, Va., May 5, 2026 /PRNewswire/ — RIVANNA®, developer of AI-powered clinical decision-support solutions, today announced that it has been nominated for MedTech Scale-Up of the Year at the MedTech World Awards 2026 | North America. Public voting is open through Friday, May 8, 2026, with category winners to be announced at the inaugural North American Awards Gala on May 11, 2026, at the Hilton West Palm Beach in Florida.

The MedTech Scale-Up of the Year category honors a growth-stage company successfully scaling revenues, partnerships, and adoption across the global medical technology ecosystem. Nominees across the program’s 22 categories were selected through a structured process led by the MedTech World Steering Committee, with category winners determined by a combination of expert evaluation and public voting from the global MedTech community.

“We have built RIVANNA on validation earned from the most rigorous technical buyers in healthcare: competitive federal awards translated into FDA-cleared products, each paired with a commercial program that meets clinicians where they work,” said Will Mauldin, PhD, Co-founder and CEO of RIVANNA. “Being nominated for MedTech Scale-Up of the Year is a meaningful affirmation of that approach and the team executing it.”

Public voting closes Friday, May 8, 2026. Members of the MedTech community are invited to support RIVANNA’s nomination at the official voting page: vote here.

The award nomination follows a year of measurable scaling for RIVANNA:

In October 2025, RIVANNA reported on being named a finalist in MedTech Innovator’s 2025 Early-Stage Grand Prize competition, selected from nearly 1,500 global applicants to represent the top 4% of medtech innovations worldwide.In December 2025, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of its Accuro® 3S Needle Guide Kit consumables, building on existing Accuro 3S device clearance.In April 2026, RIVANNA reported on peer-reviewed findings, published in 2025 in the Journal of Emergency Medicine (DOI: 10.1016/j.jemermed.2025.11.011), showing that the Accuro® XV musculoskeletal imaging system enables non-physician operators to acquire diagnostic-quality scans after just one hour of hands-on training.In May 2026, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of the Accuro® XV Diagnostic Ultrasound System for musculoskeletal imaging, authorizing commercial use across hospital and clinic settings.The company’s clinical program now spans eight sites nationwide with more than 1,500 patients enrolled.

The 2026 MedTech World Awards | North America, powered by Blue Goat Cyber, will be presented Monday, May 11, 2026, at the inaugural North American Awards Gala at the Hilton West Palm Beach, marking the first time the MedTech World Awards have been hosted in the United States.

About the MedTech Scale-Up of the Year Award
Presented by MedTech World, the MedTech Scale-Up of the Year category recognizes growth-stage medical technology companies demonstrating strong commercial momentum, expanding partnerships, and accelerating real-world adoption. The award is one of 22 categories spanning innovation, clinical excellence, regulatory strategy, investment, and leadership across the global MedTech ecosystem.

About RIVANNA
RIVANNA® is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company’s platform automates complex anatomical analysis at the point of care, enabling faster, more confident clinical decisions while reducing variability and expanding access to advanced capabilities. The first applications target significant market opportunities in regional anesthesia and fracture care. RIVANNA has built a proven FDA regulatory track record across its Accuro® platform, with device clearances for Accuro® 3S (spinal needle guidance) and Accuro® XV (musculoskeletal imaging), a portfolio of supporting cleared consumables, and AI software modules advancing through regulatory review. The company is backed by 100+ patents and validated through clinical partnerships with leading academic medical centers. RIVANNA is headquartered in Charlottesville, Virginia, and operates an FDA-registered, ISO 13485:2016-certified manufacturing facility. Learn more at rivannamedical.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rivanna-nominated-for-medtech-scale-up-of-the-year-at-medtech-world-awards-2026–north-america-302763342.html

SOURCE RIVANNA

Continue Reading

Technology

D2L Launch Week Highlights Latest Product Releases

Published

on

By

Latest innovations are designed to save time, simplify workflows, and help drive better learning outcomes

TORONTO, May 5, 2026 /PRNewswire/ – D2L, a global leader in learning innovation, hosted its first-ever D2L Launch Week, a four-day virtual webinar series spotlighting the company’s latest product innovations across D2L Brightspace in 2026.

Throughout the week, D2L showcased a range of product releases through live demos and practical customer use cases, highlighting how institutions, school districts and organizations can help to drive engagement and improve learning outcomes. The featured updates include enhancements to D2L Lumi for idea generation, intervention suggestions, quiz creation and summarization; tools to strengthen parent and guardian outreach; and administrative capabilities designed to help large organizations delegate course and configuration management more effectively.

“We’re proud to showcase the ways D2L continues to innovate to help make learning more personalized, efficient, and scalable,” said Christian Pantel, Chief Product Officer at D2L. “From new D2L Lumi features to enhanced communication tools and more flexible distributed administration capabilities, these updates are designed to help our customers save time, improve usability, and deliver better learning experiences at scale.”

Enhancements to D2L Lumi

Among the new capabilities were several updates to D2L’s AI-native tool, D2L Lumi, designed to improve usability, transparency, and alignment across workflows, including:

D2L Lumi Ideas: Generates assignment and discussion ideas directly within Brightspace, making it easier to generate high quality content aligned to learning outcomes.D2L Lumi Insights: Gives educators access to learning intervention suggestions, designed to provide recommended next steps based on learner data.D2L Lumi Quiz: Helps educators generate questions from multiple course content topics and includes a more streamlined question-generation workflow.D2L Lumi Summary: Supports summarization from more content sources, including nested submodules, and can give educators the ability to preview and adjust source text before summarization.

Updates to Parent and Guardian Communications

D2L also introduced new parent and guardian communication enhancements to help K-12 educators strengthen engagement beyond the classroom. Teachers can now send bulk emails to all parents and guardians associated with students in their class. For individual student outreach, teachers can also email parents and guardians of a specific learner, making it easier to share timely updates on student progress and classroom activity.

Manage Distributed Administration at Scale

Distributed Administration gives organizations more flexibility to delegate administrative responsibilities across organization levels. With Distributed Administration, administrators can manage specific areas, enabling them to oversee courses while helping to reduce bottlenecks and free up time.

Learn more about the latest product releases showcased at D2L Launch Week.

About D2L   
D2L is transforming the way the world learns, helping learners achieve more than they dreamed possible. Working closely with customers all over the world, D2L is on a mission to make learning more inspiring, engaging and human. Find out how D2L helps transform lives and delivers outstanding learning outcomes in K-12, higher education and businesses.

D2L Media Contact
PR@D2L.com
X: @D2L
© 2026 D2L Corporation.

The D2L family of companies includes D2L Inc., D2L Corporation, D2L Ltd, D2L Australia Pty Ltd, D2L Europe Ltd, D2L Asia Pte Ltd, D2L India Pvt Ltd, D2L Brasil Soluções de Tecnologia para Educação Ltda and D2L Sistemas de Aprendizaje Innovadores, S. D2 R.L de C.V., and H5P Group AS.

All D2L and H5P marks are owned by the D2L group of companies. Please visit D2L.com/trademarks for a list of D2L marks. All other trademarks are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/d2l-launch-week-highlights-latest-product-releases-302763345.html

SOURCE D2L

Continue Reading

Trending